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Herein we describe the synthesis of (±) platensimycin, a potent antibiotic against 
gram-positive bacteria.  The first chapter reviews (±) platensimycin’s isolation, biological 
profile and previously reported studies relevant to the area.  The second chapter describes 
our initial efforts to synthesize (±) platensimycin.  The third chapter accounts our second 
generation synthesis and its completion.  The fourth chapter entails the experimental 
details of the important compounds in our synthesis.  
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Chapter 1:  Platensimycin: The New Antibiotic  
 
1.1 Introduction 
The increasing number of antibiotic resistant bacteria and lack of new antibiotics, 
has greatly increased the need for researchers to make new discoveries. In 2006, Merck 
Laboratories discovered two new natural products with antibacterial properties, 
platensimycin 1 and platencin 2 (Figure 1.1.1).
1
  They are produced by Streptomyoces 
platensis, a bacterium discovered in soil samples from South Africa and Spain. It was 
determined that both platensimycin and platencin function as potent inhibitors in cellular 
lipid biosynthesis, in a novel mode of action. Furthermore, they displayed great 

















Platensimycin (1) Platencin (2)  
Figure 1.1.1: Structures of Platensimycin and Platencin 
 
 To complement its appealing antibacterial properties and novel mode of action, 
platensimycin also has a very unusual molecular architecture.  It consists of two major 
fragments, a tetracyclic acid enone core and a 3-amino-2,4 hydroxy benzoic side chain 
(Figure 1.1.2)   Although the disconnection at the amide bond is obvious, developing a 
 2 
strategy for the synthesis of the individual components constitutes a synthetic challenge.  











(A) (B)  
 
Figure 1.1.2: (A) tetracyclic acid enone core (B) amino benzoic acid side chain 
 
1.2 Isolation and Structural Determination 
 Platensimycin was discovered by the use of new high throughput screening 
method developed at Merck.
2
  This method employs an antisense differential sensitivity 
technique.  Once it was determined that platensimycin was produced by Streptomyces 
platensis, fermentation was implemented to gain access to greater amounts of the natural 
product. The resulting broth was purified using a two-step process using Amberchrome 
and reverse phase HPLC chromatography. 
 The molecular formula was determined using HRESIFTMS and corroborated 
using 
13
CNMR.  Various 
1
HNMR techniques (NOSEY, NOED, HMBS) were used to 
help determine the molecular structure and relative stereochemistry.  Finally, 
crystallographic analysis of a 6’-bromo platensimycin (Figure 1.2.1) allowed for the 
















Figure 1.2.1: 6’-bromo platensimycin 
 
1.3 Biological Profile 
 Discoveries in the realm of antibiotics in the last 50 years have been few and with 
limited success.  Two of these in particular are cerulenin and thiolactomycin which target 
the FabF enzyme, a target for antibacterial agents for the past 30 years.
4
  Fab F is an 
elongation condensing enzyme, a key component in fatty acid biosynthesis that is highly 
conserved among many important bacteria. As such, a successful drug designed to 
specifically bind FabF will make a potent antibiotic and allow it to be used for a wide 
range of pathogens.  
 Through high throughput screening techniques and in vitro experiments it was 
determined that platensimycin inhibited S. aureus FabF and Escherichia coli FabF/B 
enzymes with IC50 values of 48 and 160 nM, respectively.  These inhibition 
concentrations were very promising when compared to IC50 values for cerulenin and 
thiolactomycin which range from 1.5-13 µg/mL.  Astonishing results were also obtained 
for MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-
Resistant Enterococci) with MIC values of .1-1 µg/mL.  Furthermore, whole-cell labeling 
experiments show that platensimycin specifically bounds to  S. aureus (without 
interfering with DNA, RNA, protein, or cell wall biosynthesis) with concentrations up to 
500 µg/mL.
1
     
 4 
 Promising results were also obtained in in vivo experiments using mice.  Mice 
infected with S. aureus, showed in a decrease of 4-5 log reduction of infection after 24 
hours with treatment of platensimycin (100 µg 
-
h).  It is also important to note that no 
toxicity was observed in this particular case nor was it observed in examples where the 
mice were treated for elongated periods of time, up to 8 days.
1
  
 The major drawback of platensimycin is the need for continuous administration in 
order to be effective. This has spurred a significant interest in the synthesis of 




 Platensimycin’s potency and selectivity have made it an ideal candidate for more 
extensive research. Although it suffers from a poor pharmacokinetic profile, it still has 
the potential to have a major impact in the antibiotic arena.  With many promising 
attributes, platensimycin has become a prime target for scientists.   
 
1.4 Previous Syntheses 
With an impressive pharmacological profile and complex molecular structure it is 
no surprise that platensimycin has been the focus of many synthetic groups, including our 
own.  Since 2006 there have been two total syntheses
7,8
, numerous formal 
syntheses
9,10,11,12,13,14
 and formation of platensimycin analogues.
15,16
  The proceeding 
sections will focus on key syntheses.  The first will be the initial synthesis by Nicolaou, 
which has been the foundation for nearly all of the formal syntheses published.  This will 
be succeeded by the work from the Mulzer group, which employs a similar strategy to 
our own.  Lastly, I will briefly address the key reactions in the asymmetric syntheses of 
platensimycin.  
 5 
1.4.1 The Nicolaou Synthesis 
 In 2006 the Nicolaou group published the first total synthesis of platensimycin.
7
  
They started with commercially available ethoxy enone 3 and performed a sequential 
alkylation to give compound 4 (Scheme 1.4.1).  Compound 4 was reduced, hydrolyzed 
under acidic conditions and the allylic alcohol was re-protected to produce enone 5.  
Cylcoisomerization of compound 5 using a ruthenium catalyst gave spirocycle 6, in a 1:1 
distereomeric ratio.  They overcame this obstacle in subsequent work.  Saegusa oxidation 
produced dienone 7, which upon exposure to acid gave aldehyde 8.  Radical cyclization 
with SmI2 afforded compound 9 in a 2:1 ratio favoring the desired diastereomer.  Even 
though they were able to obtain the desired isomer as the major product they did so in 
poor yield (42% total yield).  Next, compound 9 underwent an intramolecular cyclization 
to give compound 10, the tetracyclic core of platensimycin.  It is important to note that 
this compound is the target for all formal syntheses.  Another set of sequential alkylations 
led to disubstituded enone 12. Finally, olefin metathesis with Grubbs second generation 
catalyst and two subsequent oxidations gave carboxylic acid 15.  It was noted by the 
authors that more direct route could have been achieved using methyl acrylate instead of 
allyl bromide, but they were unable to obtain any conclusive results.   With the first half 
of the platensimycin synthesized they directed their efforts toward the amino benzoic acid 














































3) DIBAL-H, Tol, 
    -78-20C, 2h;
    MeOH, 2N aq HCl
    -2022C, 2h
4) TBSCl, Imid., 
    DMF, rt, 20 min
   84% (2 steps)
CpRu (MeCN)3 PF65)
6) LHMDS, TMSCl,
    THF, -78C, 2 h
TBSO











THF, -78rt, 6h, 92%
THF, -78rt, 13h, 97%
cat. Acetone, rt
1.5h, 1:1 d.r.,92%
7) Pd(OAc)2, MeCN, 
    rt, 1.5 h,
    68% (2 steps)
8) 1N aq HCl/THF (1:1)
rt, 2 h, 85%;
9) SmI2 (0.1m in THF), HFIP,
    THF/HMPA(10 :1), -78C, 1 min,
    46%, ca. 2:1 d.r.
10) TFA/DCM (1.8:1)
0 C, 1.5 h, 87%
11) KHMDS, MeI, THF/HMPA (5 :1), 
      -7810°C, 2 h, 88%
12) KHMDS, 
      allyl iodide
THF/HMPA(5 :1), 
-7810°C, 2 h, 79%




      2-methyl-2-butene,
      NaH2PO4,
        tBuOH/H2O (1:1),
      22C, 15 min, 95%.
   Scheme 1.4.1: Synthesis of the tetracylic acid enone core 
 7 
The second half of the molecule started with commercially available 2-nitro 
resorcinol, 16 ($8/g) (Scheme 1.4.2).   Protection of the hydroxyl groups and subsequent 
reduction of the nitro group gave aniline 18.  The aniline was protected under standard 
BOC conditions to afford compound 19.  The protected aniline was then silylated and 












b) H2, Pd/C cat. d) nBuLi, TMSCl;
16: R = H
17: R = MOM
18: R = H
19: R = Boc
20: R = Boc
21: R = H
a) NaH,
    MOMCl





Scheme 1.4.2: Synthesis of the benzoic acid side chain 
 
thermolysis to produce benzoic acid moiety 21.  An improved method for the synthesis of 
the trisubstituted benzoic acid chain was later developed by the Nicolaou group.      
 The last sequence of reactions starts with the coupling of the tetracylic acid enone 
core 15 and compound 21 under standard peptide coupling conditions using HATU 
(Scheme 1.4.3).  Hydrolysis of the methyl ester and removal of the MOM groups 












b) LiOH; then aq 
    HCl
1
21 15  
 8 
Scheme 1.4.3 Peptide coupling.  
 
The Nicolaou group was able to achieve the synthesis of the tetracylic core in 15 
linear steps and the total synthesis of platensimycin in 22 overall steps.  Although their 
strategy suffered from stereochemical issues and low yields in key transformations, they 
produced the inaugural synthesis of platensimycin which provided the foundation for all 
succeeding formal syntheses.  Furthermore, they were able to complete the synthesis in a 
short number of steps which still rivals the latest syntheses.     
 
1.4.2 The Mulzer Synthesis 
 In 2007 the Mulzer group published the formal synthesis of platensimcyin.
17
  This 
was of special importance to us because it directly involved the strategy we had devised, 
specifically using dienone 25 as a key intermediate.  Their synthesis began with tetralone 
22, which is commercially available and relatively inexpensive (Scheme 1.4.4).  They 
took tetralone 22 and converted it to carboxylic acid 23 in three steps using previously 
published procedures.  The resulting unsaturated carboxylic acid 23 was reduced using 










    Toluene, rt, 3h
6) TMSCHN2, 
    THF, 0C 12 h
7) TFA, -20 C











    EtOH/H2O (2:1)
    NaOH (aq)
    86% (3 steps)
Scheme 1.4.4: Formation of key intermediate 25 
 
converted to the acyl chloride and treated to TMS-diazomethane to give the beta-
hydrazido ketone.  Finally, the resulting diazoketone was treated with TFA to give 
dienone 25 in 59% yield over 3 steps.     
 Their end game started with a Grignard addition into the saturated ketone 25 to 
give tertiary alcohol 26 with both regio- and stereoselectivity albeit in low yield. 
(Scheme 1.4.5).  Compound 26 was then brominated at the γ-position using NBS.  The 
resulting brominated compound 27 possessed the appropriate stereochemistry for an 































   H2, DCM, 12hr
   72%(brsm),
   1.3:1 d.r.
5) HIO3-DMSO
DMSO, C6H12
50 oC, 8 hr, 60%
25 26
27 28
29 30 10  
Figure 1.4.5 Completion of the Mulzer Synthesis  
 
Upon treating bromide 27 with NaOMe in THF, the desired ether was formed to 
give tetracycle 28.  Compound 28 underwent global reduction upon exposure to 
Crabtree’s Catalyst to produce saturated ketones 29 and 30, giving a 1.3:1 distereomeric 
ratio.  This step suffers from poor stereoseletivity and from a low yield.  Furthermore it 
seems counterproductive to perform a global reduction only to have to reoxidize to the 
appropriate oxidation level.  Finally, taking reduced product 29 and treating it to 
oxidative conditions gave mono-oxidized product 10 in 60% yield.   
 The Mulzer group was able complete the formal synthesis of platensimycin in 12 
linear steps starting with commercially available materials. They devised a short and 
direct route to the tetracyclic core of platensimycin and did so in a protecting group free 
 11 
fashion.  Though the synthesis was efficient, it suffered from a few major drawbacks.  
First, the Grignard addition was low yielding, with an actual yield closer to 25%.  The 
reduction itself also suffered from poor selectivity and low yield.  Finally, as previously 
pointed out, it seems impractical to toggle between oxidation states (conversion of  28 to 
10 in Figure 1.4.5). 
 
1.3.3 Asymmetric Syntheses  
 In this section we will highlight the key steps, in chronological order, of the 
asymmetric syntheses of (-)-platensimycin. Before we go into detail on work not yet 
addressed, I will briefly state that both the Mulzer (2010)
18
 and Nicolaou (2009)
19,20
 
groups were able produce enantioselective syntheses.  They performed key 
stereocontrolled reactions in the reduction of the unsaturated acid 23 and the 
cycloisomerization of compound 5, respectively.   
 In 2007 the Yamamoto group published the second asymmetric synthesis of (-)-
Platensimycin.
21
  Their strategy involved two key transformations in which they were 
able to enforce the desired stereochemistry (Scheme 1.4.6).  The first reaction involved 
an Diels-Alder reaction with methyl acrylate and cylcopentadiene using a Brønsted acid 
assisted chiral Lewis acid (34+35).  They obtained cycloadduct 33 in high yield and high 
enantioselectivity. The second step, coincidently the final step of their synthesis, was a 
stereoselective intramolecular Michael addition of bicyclic compound 36.  They obtained 









DMF, r.t. 5 days
then 2N NaOH(aq)
0 oC to r.t., 40 min


























DCM, - 78 C, 14h










Scheme 1.4.6:  (a) Stereoselective Diels-Alder (b) Stereoselective Michael addition 
 
 The next body of work was published by the Corey group.
22
  The first reaction 
consists of an enantioselective conjugate addition of a 2-propenyl group into enone 37 
using a rhodium catalyst (Scheme 1.4.7).  The addition product was obtained in high 
yield and high enantioselectivity.  The other step was a high pressure, rhodium catalyzed 






























Figure 1.4.7: (A) Enantioselective conjugate addition (B) Diastereoseletive reduction 
 
 Matsuo and coworkers also took advantage of a stereoselective Diels-Alder 
reaction (Scheme 1.4.8).
23
  They treated diene 40 with enone 39 to give bicyclic 











1) neat, 180 oC
2) TFA, DCM
     83%
+




Scheme 1.4.8: Matsuo’s diastereoselective Diels-Alder reaction 
 
 Two years later the Lear
24
 group and Canesi
25
 groups published asymmetric 
syntheses. The Lear group utilized an organocatalyst in a diastereoselective reduction. 
They took dienone 43 and treated it to tert-butyl D-phenylalanine then exposed it to 
sequential Hantzsch and Pd/C based reductions to produce ketones 29 and 30 (Scheme 
1.4.9).  Although they were able to isolate compounds 10 and 44, they observed large of 
amounts of degradation upon purification, so the crude was directly submitted to the 
second reduction.    
 
 



































 The Canesi group utilized a stereoselective oxidative Prins-Pinacol tandem 
process to transform compound 45 to spirocycle 46 in 64% yield over 2 steps (Scheme 
1.4.10).   This spirocycle is similar to intermediate 6 in the Nicolaou synthesis and the 
succeeding transformations mirror closely what was done in the Nicolaou synthesis to 





   -20 oC/ 2min
2) H2O2/ 5min




45 46  
Scheme 1.4.10: Formation of spirocycle 46   
 
 The latest asymmetric synthesis was published by the Nakada group which 
centered on an enantioselective catalytic asymmetric intramolecular cyclopropanation.
26
  
They synthesized -diazosulfone 47 and subjected it to a chiral copper catalyst to 
produce cyclopropyl compound 48 in 72% yield (Scheme 1.4.11).  This compound was 
elaborated to an intermediate in the Snider synthesis and eventually transformed to enone 















Tol, r.t., 11 hr
72 %, 95% ee
15 mol %
47 48  
Scheme 1.4.11 Enantioselective formation of cyclopropane 48 
 
 Although these formal syntheses allowed for the asymmetric synthesis of (-)-
platensimycin, they had many shortcomings.  Devising an asymmetric strategy required 
many of these groups to add several steps, accept low yields and in some cases report 
comparable stereoselectivities.  To date the Nicolaou asymmetric synthesis offers the best 
example of an asymmetric synthesis.   
 
1.5 Conclusions 
 Platensimycin’s potency, selectivity and molecular complexity have made it an 
appealing target for synthetic chemists. Though a multitude of syntheses had been 
published, we believed a more concise and direct route could be developed. In the 
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Chapter 2: First Generation Synthesis  
 
2.1 Introduction  
Platensimycin is a potent antibiotic against gram-positive bacteria that was 
discovered in 2006 by Merck.  Complementing its impressive biological profile is its 
molecular complexity.  The unusual structural motif of platensimycin has aroused 
significant attention from the synthetic community.  Although many syntheses have been 
published we felt that we could produce a more precise and stereospecific synthesis.   
 
2.2 Synthetic Approach  
We devised a strategy beginning with 6-methoxy-1-tetralone 22.  Tetralone 22 
was chosen because it is both commercially available and inexpensive.   Tetralone 22 is 
elaborated to carboxylic acid 24.  Carboxylic acid 24 is converted to dienone 25, a 
compound that has been previously produced in gram scale.   
 The next phase of the synthesis begins with a Grignard addition into dienone 25 to 
give tertiary alcohol 26.  Dienone 26 is converted to dialkylated compound 49, providing 
the appropriate oxidation level at the enone.  Hydroboration and cyclization of compound 
49 gives cyclic ether 50.  Hydrolysis of compound 50 would afford carboxylic acid 15, 
thereby completing the formal synthesis.  Successful execution of this route would 



























Scheme 2.2.1: Synthetic Approach 
 
2.3 Background for the Dienone 25 
 In the early 1970’s Mander published a series of papers displaying the synthesis 
of various intermediates directed toward the formation of tetracylic diterpenes.
1,2,3,4
  The 
structure that caught our attention was dienone 25 (Figure 2.3.1).   It piqued our interest 








Figure 2.3.1: Mander’s Dienone 25 and Nicolaou’s Enone 10 
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enone 10.    Mander went on to show that compound 25 reacts stereoselectively upon 
treatment with sodium borohydride (Figure 2.3.2).  These results lead us to believe that 












Figure 2.3.2: Examples of regioselectivity 
 
2.4 Synthesis of Dienone 25  
 The synthesis of enone 25 began with the acylation of 6-methoxy-1-tetralone 22.
5
 
Tetralone 22 was added to a mixture of dimethyl carbonate and NaH and heated to 
provide α,β-ketoester 54 (Scheme 2.2).  α,β-ketoester 54 was directly reduced to methyl 
ester 55.
6
  The methyl ester was hydrolyzed to provide carboxylic acid 24 as an off white 
solid.  Carboxylic acid 24 was produced in 84% yield over 3 steps and with a single 
purification.  It is worthwhile noting that both the R- and S-enantiomers of acid 24 are 
available from the microbial reduction of 1-tetralone-2-carboxy ethyl esters.
7
  Hence, it is 
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Scheme 2.4.1: Synthesis of dienone 25 
 
 Carboxylic acid 24 was converted to acyl chloride 56 upon treatment with thionyl 
chloride.  Acyl chloride 56 was treated with freshly prepared diazomethane to give -
diazoketone 57.  The resulting mixture was exposed to TFA to give key intermediate 25.  
Dienone 25 was obtained in 61% yield over three steps and with a single purification.   
 We were able to obtain dienone 25 in 6 steps, 1 less step than the Mulzer group, 

















































2.5 Grignard Addition 
 As we were approaching this step in our synthesis, the Muzler work was 
published.  Although they were fruitful in producing the tertiary alcohol 26, it was 
reported as an ambiguous 71% yield (brsm = by recovered starting material, Scheme 
2.5.1).  It was no surprise that when Mulzer’s conditions were used a paltry yield of 26% 





1) MeMgCl (1 eq), THF




Scheme 2.5.1: Mulzer’s conversion of dienone 25 to tertiary alcohol 26 
 
 We began exploring this transformation by choosing Grignard reagents with 
different halogen counteranions (Table 2.5.1).  The differences between MeMgI, 
MeMgBr, and MeMgCl were minimal (Entry A-C).  For quality purposes fresh solutions 
of MeMgBr and MeMgI were prepared but offered no advantage over the commercially 
available reagents (Entry D-E).  The reactions performed with different solvents yielded 
unreacted starting material (Entry F-K).  This was possibly due solubility issues.  The 
reactions were normally run at 0.3 M because it was determined this was the optimal 
reaction concentration (Entry A-C).  However, using dimethyl ether or dimethoxy 
methane (DMM) required the reaction to be diluted to .03 M.  We believe this huge 
decrease in reaction concentration was responsible for our results.  Finally, varying the 
reaction temperature had little impact on the yield (Entry L).  Having exhausted the 
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A MeMgI  -78 THF 4  25 
B MeMgBr -78 THF 4  24 
C MeMgCl -78 THF 4  28 
D MeMgI  -78 THF 4  23 
E MeMgBr -78 THF 4 22 
F MeMgI  -78 Et2O 4  sm 
G MeMgBr -78 Et2O 4  sm 
H MeMgCl -78 Et2O 4  sm 
I MeMgI  -78 DMM 4  sm 
J MeMgBr -78 DMM 4  sm 
K MeMgCl -78 DMM 4  sm 
L MeMgI  -78 to rt THF 4  25 
Table 2.5.1: Grignard Addition 
 
 The reaction conditions from the Grignard addition were maintained with the 
exception of the nucleophile source (Table 2.5.2).  Using MeLi gave a 13% yield (Entry 
A).  All other reagents failed to produce any positive results (Entry B-E).
8,9
 When the 
reactions were run at 0 ºC and allowed to warm to ambient temperature, only TiCl3Me 
managed to give any of the desired product albeit in low yield (Entry F-H).
10,11
  Although 
this was a low yield, further reactions were performed using TiCl3Me.  When the reaction 
was run at higher temperatures or with an excess of the reagent, a multitude of 
unidentifiable compounds were obtained (Entry I,K).  Changing the solvent resulted in 




Reagent       
(1 eq) 
Temp (°C) Solvent Time (h) 
Yield 
(%) 
A MeLi -78 THF 4  13 
B (CH3)2CuLi -78 THF 4  sm 
C TiCl3Me -78 THF 4 sm 
D Al(CH3)3 -78 DCM 4 0 
E CH2(MgBr)2 -78 THF 4 0 
F MeLi 0-rt THF 4  sm 
G TiCl3Me 0-rt THF 4  5 
H (CH3)2CuLi 0-rt THF 4  sm 
I TiCl3Me rt-50C THF 4  0 
J TiCl3Me 0-rt DCM 4 sm 
K 
TiCl3Me        
(3 eq) 
0-rt THF 4  0 
Table 2.5.2: Use of different methylating sources 
 
 One thing that had caught our attention was that the experiments run with MeLi 
(Table 2.5.2 Entry A,E).  We were partially surprised to have not obtained the desired 
product at 0 °C.  This led us to believe that a competition was occurring between the 
reagent acting as base instead of nucleophile.  We devised a quick and easy experiment 
where dienone 25 was treated to previous conditions except that the reaction was 
quenched with D2O instead of H2O (Scheme 2.5.2).  Deuterated compound 57 was 
isolated and the 
1
H NMR indicated the incorporation of deuterium by the disappearance 
of the indicated proton.  These results strongly suggested it was an issue of enolization 










-78 oC, 4 hr
2) D2O
25 57  
Scheme 2.5.2: Deuterium exchange experiment 
 
 The issue of enolization versus addition is not without precedent. It has been 
shown that using CeCl3 helps to deter the path of enolization and favor Grignard 
addition.
12
  Although, how it actually impedes enolization is not completely understood.  
Reaching this conclusion, the experiments using Grignard reagents were re-run in the 
presence of CeCl3 (Table 2.5.3).  These reactions were run with 1 equivalent of CeCl3 
and at a 0.08 mM concentration.  Running the reaction under previous conditions 
produced poor results.  Increasing the reaction temperature had little to no effect with 
about 50% decrease in yield (Entry A-C).  Preparing our own Grignard reagent gave 
similar results (Entry D).  Increasing the reaction temperature had little to no effect 












A MeMgI  -78 THF 4  15 
B MeMgBr -78 THF 4 12 
C MeMgCl -78 THF 4  15 
D MeMgI  -78 THF 4 14 
E MeLi -78 THF 4  sm 
F MeMgI  -78-rt THF 4  13 
G MeMgBr -78-rt THF 4  11 
H MeMgCl -78-rt THF 4  14 
I MeLi -78-rt THF 4  sm 
Table 2.5.3: Grignard addition in the presence of CeCl3 
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(E, I).  We had reached major roadblock and had to seriously consider continuing this 
feat or accept the yields obtained from Mulzer’s work.   
 We came up with one final idea before retreating; we would simply increase the 
equivalents of the Grignard reagent (Table 2.5.4).  As the equivalents of MeMgCl were 
increased, the yield increased as well (Entry A-C).  Eventually it was determined that best 
yield was obtained using 3 eq of MeMgCl (Entry C).  A 61 % isolated yield of tertiary 
alcohol 26 represents almost a 250% increase in yield from the Muzler procedure (Table 
2.5.4).  
 








A MeMgCl 1 -78 THF 4  28 
B MeMgCl 2 -78 THF 4  46 
C MeMgCl 3 -78 THF 4  61 
D MeMgCl 4 -78 THF 4  57 
E MeMgCl 5 -78 THF 4  55 
Table 2.5.4:  Increasing the amount of MeMgCl 
 
These experiments were repeated with other Grignard reagents and MeLi but gave 
inferior results.  Varying temperature and reaction times also failed to provide further 
improvement. 
 Ultimately, dienone 25 dissolved it in THF and MeMgCl (3 eq.) was added to 
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Scheme 2.5.3: New found conditions for the formation of tertiary alcohol 26 
 
2.6 Alkylation 
 Now that the Grignard addition had been adequately solved, we continued with 
the subsequent sequence of alkylations.  Dienone 26 was submitted to standard alkylating 
conditions to give -methyl dienone 58 in good yield and without any trace of the 
germinal dimethylation product (Scheme 2.6.1).
13











Scheme 2.6.1: Methylation of dienone 26 
 
 The succeeding alkylation with methyl acrylate (MeA) was performed under 
similar conditions as the methyl addition but was unfruitful (Table 2.6.1, Entry A).
14
  
Varying the conditions provided similar results. Increasing the equivalents of methyl 
acrylate or 
t
BuOK resulted in recovered starting material (Entry B-D).  Increasing the 
temperature from ambient temperature to 60 ºC resulted in a mixture of unidentifiable 
compounds (Entry E).  Utilizing triton-B, previously shown to affect the desired 
transformation, resulted in recovered starting material (Entry F).
15
  Similar experiments 
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were implemented using ethyl bromoacetate in lieu of methyl acrylate, but these 












Scheme 2.6.2: Attempted alkylation of dienone 58 
 










A tBuOK 2.2 1 tBuOH rt 6  sm 
B tBuOK 2.2 2 tBuOH rt 6  sm 
C tBuOK 2.2 5 tBuOH rt 6  sm 
D tBuOK 4 1 tBuOH rt 6  sm 





2.2 1 DCE rt-reflux 12  sm 
Table 2.6.1: Conditions for methyl acrylate alkylation of 58 
 
 It was evident that the formation of the quaternary center was not going to be as 
straight forward as imagined.  We believed that we might affect this transformation by 
simply reversing the order of alkylation.  Dieneone 26 was treated to alkylating 
conditions but this proved to be an unfruitful endeavor (Table 2.6.2). Varying the amount 
of methyl acrylate had no effect (Entry A-C).  When the reaction was heated, an 
inextricable mixture was obtained (Entry D).  Lack of success led us to abandon the use 













Scheme 2.6.3: Attempted alkylation with methyl acrylate   
 






A tBuOK 1 tBuOH rt 6  sm 
B tBuOK 2 tBuOH rt 6  sm 
C tBuOK 5 tBuOH rt 6  sm 
D tBuOK 1 tBuOH 60 6  0 
Table 2.6.2: Conditions for alkylation of dienone 26 with methyl acrylate 
 
 We decided to pursue an alkylation with allyl bromide.  Since the Nicolaou group 
already had success with allyl bromide as an alkylating agent, we saw this as a viable 
option.  Although this would provide an earlier intermediate in the Nicolaou synthesis 
than originally planned, successful execution would still provide a short and concise 
formal synthesis.  
 Following the previous rationale, dienone 26 was alkylated with allyl bromide to 
give -allyl dienone 60 in 67% yield (Scheme 2.6.4).  The second alkylation with MeI 
was attempted but without success.  The reaction was monitored via TLC and quenched 
upon consumption of the starting material.  Following purification only dienone 26 was 
recovered.  Initially this was a bit confusing.  The reaction was repeated additional times, 
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Scheme 2.6.4: Allylation and subsequent alkylation of dienone 26 
 
results.  We postulated that a competition between O and C-alkylation was occurring, 
with O-alkylation dominating the reaction.  We proceeded to reverse the sequence of 
alkylation believing that if O-alkylation was indeed impeding the formation of the 










62 61  
Scheme 2.6.5: Proposed Claisen rearrangement 
  
 On a side note, the alkylation of dienone 26 with methyl acrylate was revisited. 
This was in response to work published by the Corey group of a platensimycin analog.
16
  
They reported the alkylation of enone 63 with methyl acrylate in good yield (Scheme 
2.6.6).  However, when this alkylation was attempted using their method none of the 
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desired product was obtained.  Minor modifications were made to the procedure but all 
















Scheme 2.6.6: Corey’s alkylation with Methyl Acrylate 
 
 Subjecting -methyl dienone 58 to deconjugative alkylating conditions gave 
epimers 61 and 65 in a 1:3 ratio (Scheme 2.6.7).  Structures of enones 61 and 65 were 
assigned by IR and NMR.  Their relative stereochemistries were later assigned through 
crystallographic data.  It was determined that the minor product, enone 61, was that of the 
desired stereochemistry (Figure 2.6.1).  We were surprised to obtain two different 
compounds, since we expected to have a bias toward the desired stereochemistry.  This 
notion stems from the Nicolaou synthesis, where they observed complete 
stereoselectivity in their sequence of alkylations (Scheme 1.3.1.).  We had assumed that 
the structure of dienone 26 was comparable to the structure of enone 10 that we would 
















Scheme 2.6.7: Enones 61 and 65 
 
Figure 2.6.1: Crystal Structure of enone 61   
  
 Upon closer examination of the structure, published literature and molecular 
models we realized that the critical difference between our intermediate and those 
published was the hybridization of the -carbon (Figure 2.6.2).  In the structure of enone 
61 and 65 the -carbon is sp
2
 hybridized and in the Nicolaou synthesis it is sp
3
 
hybridized.  This change of hybridization has a major influence on the stereochemistry at 
the α-carbon due to the differences in conformation because of the γ-carbon (Figure 
2.6.2).  
 






          
Figures 2.6.2: Steric effects caused by difference in hybridization 
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  The top face of Nicolaou’s intermediate 10 is unavailable to electrophiles do to 
the steric congestion from the axial methylene groups (bold bonds) (Figure 2.6.2).  This 
conformation gives complete stereoselectivity in forming the -quaternary center.  As 
can be seen from the crystal structure, the -carbon of enone 61 is trigonal planar, forcing 
the bond between the - and -gamma carbons (highlighted green) to be skewed down. 
This geometric restriction forces the -methylene (highlighted orange) to be moved away 
from the top face, exposing the top of the molecule to electrophiles.  It is this difference 
in hybridization that has reversed the stereoselectivity of this alkylation.  
 
2.7 Conclusion 
We were successful in obtaining dienone 25 in gram quantities and in one step 
less than the Mulzer synthesis.  Furthermore, were able to improve the Grignard addition 
giving us an actual yield as opposed to a “brsm” yield.  When we were unsuccessful in 
using methyl acrylate to install the α-quaternary center, we opted to use allyl bromide.   
Although success was met in forming the -quaternary center using allyl bromide, the 
resulting mixture of enones favored undesired epimer 65 in a 3:1 ratio. We were able to 
surmise that the hybridization at the -carbon had enough influence to affect the 
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Chapter 3:  Second Generation Synthesis 
 
3.1 Introduction  
As we have not yet achieved the desired stereoselectivity, we went on to devise a 
new strategy that would enforce the desired selectivity.  From the Nicolaou synthesis and 
close examination of our work we knew it was crucial to form the ether linkage prior to 
alkylation.  Consequently, our second generation strategy would revolve around this idea. 
 
3.2 Synthetic Approach  
Our new strategy started with dienone 26.  Dienone 26 would be converted to 
extended enol ether 66.  Epoxidation of enol ether 66 would give epoxide 67.  Hydrolysis 
of enol ether 67 would afford γ-hydroxy dienone 68.
1,2,3
  A hydroxyl-directed reduction 
of dienone 68 to enone 69 followed by cyclization would give final product 10.  Enone 
10 was chosen as our new goal because the succeeding alkylation had already been 
successfully accomplished by the Nicolaou group. 
 40 
 
Scheme 3.2.1: Route to cyclic either 10. 
 
3.3 Formation of he Extended Enol Ether  
Initial attempts to make extended enol ether 66 using acetic anhydride failed to 
give any of the desired products (Scheme 3.3.1).  This transformation was then attempted 
using TBDMS to form silyl enol ether 71.  TBDMS was used because we assumed that a 
TMS group would be too labile, as can be evidenced by how readily the methyl enol 
ether postulated to form in the alkylation of compound 59, hydrolyzed.  Dienone 26 was 
treated under standard silyl enol ether forming conditions but gave mostly recovered 
starting material and a minor product (~5%).  After purification it was determined that 























Scheme 3.3.1: Formation of the extended enol ether 66. 
 
 The direct formation of γ-hydroxy dienone 68 from dienone 26 was a fortuitous 
result because it shortened our intended route by two steps (Scheme 3.3.2).  Our efforts 
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The origin of γ-hydroxy dienone 68 was uncertain so we explored this 
transformation by repeating the previous experiments.  The results were poor with yields 
of 68 ranging from 4-7 %, with no signs of the desired enol ether.  During these trials it 
was concluded that the process responsible for the oxidation at the γ-position was 
autoxidation (
3
O2).  Furthermore, a result from a concurrent literature search gave further 
support to the notion that this reaction was occurring via an autoxidation process.  Aladro 
and coworkers treated bicyclic enone 72 under autoxidation conditions to obtain γ-
hydroxy enone 73 in 100% yield (Scheme 3.4.1).
4




O2, 10 % KOH
MeOH, 100%
72 73  
Scheme 3.4.1: Aldaro autoxidation. 
 
The investigation proceeded with taking enone 26 and treating under the same 
conditions used by Aladro (Table 3.4.1).  The reactions were left open to atmosphere 
unless otherwise noted. Under these conditions only a 10% yield was obtained (Entry A).  












Scheme 3.4.2: Autoxidation of dienone 26. 
 






A KOH MeOH rt 48  10 
B KOH MeOH 60  48  0 
C KOH MeOH rt 96  8 
D tBuOK MeOH rt 48  6 
E KOH THF rt 48 3 
F tBuOK THF rt 48 3 
G* KOH MeOH rt 48  10 
                    *The reaction was run under an atmosphere of oxygen 
Table 3.4.1: Autoxidation conditions for dienone 26  
 
 time were increased. (Entry B,C).  Changing to a stronger base or changing the solvent 
also failed to produce any positive results (Entry D-F).  The use of an oxygen balloon had 
no impact on the yield (Entry G).   
 Having little success using dienone 26, α-methyl dienone 58 was used instead.  
This was done in order to mirror more closely what the Diaz group published (Scheme 
3.4.2).  By simply substituting dienone 26 with α-methyl dienone 58, γ-hydroxy 
compound 74 was obtained in 27% yield, almost a 3-fold increase in yield (Table 3.4.2, 
Entry A).    Further changes to the procedure were fruitless.  Prolonging the reaction from 
48 h  to 96 h had little effect (Entry B,C).  Changing the base or the solvent caused a 
slight drop in yield (Entry D-F).
5,6
  The use of an oxygen balloon had little impact on the 











Scheme 3.4.2: Autoxidation of α-methyl dienone 58. 
 






A KOH MeOH rt 48 h 27 
B KOH MeOH rt 72 h 21 
C KOH MeOH rt 96 h 19 
D tBuOK MeOH rt 48 h 20 
E KOH THF rt 48h 20 
F tBuOK THF rt 48h 21 
G* KOH MeOH rt 48 h 24 
         *the reaction was run under an atmosphere of oxygen 
Table 3.4.2: Autoxidation conditions for α-methyl dienone 58  
 
 Three new pieces of information were obtained from this reaction.  First, due to 
the increase in yield, enough of the product was collected to obtain an x-ray structure of 
γ-hydroxy dienone 74 and the relative stereochemistry was assigned (Figure 3.4.1).  The 
image displayed is a view from the bottom of the molecule to help show the syn-
relationship of the hydroxyl groups.  The γ-hydroxyl group was of the desired 
stereochemistry, perfectly situated for the envisioned hydroxyl-directed reduction.   
Furthermore, the γ-hydroxyl group was in proximity for the final transformation which 
was imagined to proceed under an acid catalyzed etherification via the tertiary 





Figure 3.4.1: Crystal structure γ-hydroxy dienone 74 
 
 It was discovered that a major reason for the low yield of dienone 74 was the 
formation of ketone 76 which was isolated in 16-19% yield (Figure 3.4.2).    Ketone 76 
was thought to arise from the over oxidation of dienone 74.   It was postulated that when 
the peroxide formed at the γ-position, excess base deprotonated the remaining γ-proton to 
give ketone 76.  Since it accounted for such a significant percentage of the products 
isolated, it was imperative that we find a solution.  Our initial thought was that using 











75 76  
Figure 3.4.2: Formation of ketone 73 
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the peroxide before deprotonation occurred. 
 A commonly utilized reducing agent in autoxidation is P(OEt)3.
7
  The previous set 
of trials were repeated in the presence P(OEt)3 (Scheme 3.4.3).  Overall the addition of 
P(OEt)3 caused a drop in the yield of ketone 76.  Additionally, the reaction time was 
significantly reduced.  However, there was little improvement in the yield of the desired 
compound.  The one reaction that caught our attention was the use of 
t
BuOK in THF 
(Entry E).  This set of conditions produced the lowest yield of ketone 76, while still 
providing a comparable yield of the desired product.  The reason for this was not well 
understood but we shifted our attention to using 
t















Scheme 3.4.3: Auto-oxidation in the presence of P(OEt)3. 
 








A KOH MeOH rt 2.5 26 8 
B KOH MeOH 60 2.5 0 0 
C tBuOK MeOH rt 2.5 20 7 
D KOH THF rt 2.5 21 8 
E tBuOK THF rt 2.5 23 4 
Figure 3.4.3: Conditions for the autoxidation with P(OEt)3. 
 
 Increasing the amount of P(OEt)3 which had little impact on the yield (Table 
3.4.4, Entry A-C).  Raising or lowering the reaction temperature didn’t provide any 
significant improvement (Entry D,E).  Changing the solvent to 
t


















A tBuOK  1 THF rt 2.5 25 4 0 
B tBuOK  2 THF rt 2.5 25 5 0 
C tBuOK  5 THF rt 2.5 26 4 0 
D tBuOK  1 THF 60 2.5 0 0 0 
E tBuOK 1 THF 0 2.5 19 6 0 
F tBuOK  1 tBuOH rt 2.5 22 5 0 
G tBuOK 1 
tBuOH/ 
THF(1:1) 
0 2.5 21 8 0 







I tBuOK 1 
tBuOH/ 
THF(1:1) 
-78 2.5 0 0 8 
J tBuOk 1 
tBuOH/ 
THF(1:1) 
rt 2.5 27 5 0 
K tBuOK 5 
tBuOH/ 
THF(1:1) 
rt 2.5 30 5 0 




results when THF was used (Entry F).  This new development sparked interest into using 
t
BuOH as a solvent.  Realizing that when the temperature was increased loss of starting 
material was observed we decided to experiment with lower temperatures.  THF had to 
be used as a co-solvent to prevent solidification of 
t
BuOH at lower temperatures.  
Decreasing the temperature lowered the yield slightly but gave rise to a new side product 
(Entry G-I).  It was determined that this side product was α-hydroxy enone 77 (Scheme 
3.4.4).  It was not too surprising since similar conditions have been employed to produce 
α-hydroxy ketones.
8
  Enone 77 helped us to conceive a possible mechanism for the 
autoxidation of α-methyl dienone 58 which will be later examined in detail.   When the 
reaction was performed at room temperature with in THF/
t
BuOH (1:1) mixture a slight 



















Scheme 3.4.4: Products formed from the autoxidation of 58. 
 
increased a 30% yield was obtained with a minimal amount of ketone.  These were the 
optimal conditions obtained thus far.  Changing the amount of base, reductant, ratio of 
solvents or reaction time failed to improve these results.  It is also important to mention 
that other reductants were used (PBu3, PPh3) but provided inferior results.   
 Obtaining α-hydroxy enone 77 and studying molecular models allowed us to 
suggest a mechanism for the autoxidation and help understand its stereoselectivity 
(Figure 3.4.3).  The reaction begins with deprotonation at the γ-position forming the 
extended enolate.  Single electron transfer then occurs from the negatively charged 
oxygen to triplet oxygen.  Homolytic cleavage of the alpha double bond leads to the 
formation of the carbonyl and alpha-peroxy bonds.  It is at this step that the peroxide can 
either do an 2,3 sigmatropic rearrangement or be reduced to give α-hydroxy ketone 77.
9
  
Molecular models helped us understand that proper orbital overlap for the 2,3-
sigmatropic rearrangement can only be achieved when the peroxide is on the bottom face 
of the molecule.   After the 2,3 sigmatropic shift the peroxide can either be cleaved by 
P(OEt)3 to give γ-hydroxy dienone 74 (red arrows) or the reminaing γ-proton can be 
abstracted by 
t




 Figure 3.4.3: Autoxidation mechanism. 
 
 Although we had improved our yield to a consistent 30% and greatly reduced the 
amount of ketone 76, it was still at best a modest yield.  Furthermore the best results were 







































larger scales dropped the yield significantly.  For these reasons we sought out alternatives 
in forming the γ-hydroxy dienone 74.  
 We started by attempting an allylic oxidation with SeO2 (Table 3.4.5, Entry A).  
At lower temperatures there was no visible change but when the temperature was raised 
only degradation of the starting material was observed.  Similar results were obtained for 
all the other trials as well.  When a source of electrophilic oxygen was used degradation 
of the starting material occurred (Entry B).
10
  Allylic acetate formation resulted in 
complex mixtures (Entry C-E).
11
  It was thought that successful formation of the allylic 





A SeO2, Dioxane, rt to reflux 0 
B tBuOK, tBuOOH, Et3N, 
tBuOH 0 
C Pd(OAc)2, Benzoquinone, AcOH, rt, 6 h 0 
D Pb(OAc)4, AcOH, 60 °C, 4 h 0 
E Hippuric Acid, NaOAc, AcOH, rt to reflux 0 
Table 3.4.5: Alternative allylic oxidation methods. 
 
 During this time we made another discovery in the literature.  The Yoshioka 
group had published a paper on the functionalization of the Wieland-Miescher ketone at 
the γ-position.
12
  By using water as a co-solvent they completely eliminated the presence 
of ketone 80 (Scheme 3.4.5).  Running the reaction under different conditions had 
 51 
produced a substantial amount of ketone 80.  These conditions were applied to the 













78 79 80  
Scheme 3.4.5: Yoshioka’s Autoxidation. 
 
 Running the reaction under the same conditions yielded a small amount of 
product but without yielding any of the undesired ketone 76 (Table 3.4.6, Entry A).  
When the temperature was increased or the base changed from KOH to 
t
BuOK no 
significant improvement was made (Entry B,E,F).  However, when 
t
BuOH was used as a 
co-solvent a significant improvement in yield was observed (Entry C).  Increasing the 
reaction temperature lead to a reduction in yield by about 50% (Entry D).  Unexpectedly, 
the mixture of base with a 
t
BuOH/H2O formed a biphasic system.  This observation lead 












































5  65 4 0 
Table 3.4.6: Autoxidation using Yoshioka conditions. 
 
 By screening various PTCs at 10 mol % it was determined that Bu4NBr showed 
the most promise in improving the yield so further experiments were performed using 
only Bu4NBr (Table 3.4.7).  The first trial showed improvement in yield and a reduction 
in reaction time by 2 days (Entry A).   Increasing the amount of PTC had a slight increase 
in yield but more importantly decreased the reaction time to 2 days (Entry B-F).  
Changing the solvent, base, or temperature provided inferior results.  Furthermore, this 







































100 2 rt 65 
Table 3.4.7: Autoxidation using aBu4NBr. 
 
 Through these experiments the optimal conditions for producing -hydroxy 
dienone 74 in 65% yield were obtained (Scheme 3.4.6).  Moreover, it was discovered that 
the use of water as a co-solvent helped to deter over oxidation to unwanted ketone 76.   
We were able to gain a working hypothesis as to the mechanism that was operating in the 
autoxidation.  Finally, the crystal structure was solved and showed that we had obtained 











rt, 48 h, 65%
 
Scheme 3.4.6: Optimal autoxodation conditions. 
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3.5 Hydroxyl-Directed Conjugate Reduction 
Having been able to unambiguously assign the stereochemistry of the γ-hydroxyl 
group put us in good position to attempt the desired hydroxyl directed conjugate 
reduction.  At the onset we had two ideas on how to achieve this objective.  The first was 
a reduction based on an intramolecular hydrosilylation and the second a reduction based 
on LAH.   
 We started by silylating γ-hydroxy dienone 74 to give compound 81 (Scheme 
3.5.1).  This compound was then treated to a variety of conditions to affect the conjugate 
reduction (Tabel 3.5.1).  Treating compound 81 to Wilkinson’s catalyst resulted in 
degradation of the reactant (Entray A).
13
  The use of Lewis acids resulted in desilylation 
(entry B,C).
1415
  Using I2O5 resulted in the degradation of the starting material.
16
  Having 










rt, 5 hrs, 95% SiHiPr2
74 81  











A (Ph3P)3RhCl, THF, 6 h, rt - reflux 0 
B SnCl4, DCM, -78° C, 3 h 0 
C TiCl4, DCM, - 78 °C 3 h 0 
D I2O5, rt, DCM, 5 h 0 
Table 3.5.1:  Conditions for the intramolecular hydrosylation.  
 
 The idea for the LAH reduction stemmed from work published by the Liotta 
group (Scheme 3.5.2).
17
  They treated dieone 82 with LAH and obtained diastereomer 83 
in 90% yield.  These conditions were taken and applied to γ-hydroxy dienone 74 (Table 
3.5.2).  All the reactions were done in THF with LAH (1eq).  When the reaction was 
done at ambient temperature a distribution of three compounds were isolated, enone 84, 
85, and dieneone 74 (Entry A).  As the temperature was decreased a greater amount of 
enones 84 and 85 were isolated (Entery A,C,E).  When the reaction continued until 
complete consumption of dienone 74, low yields and poor mass balance were observed 
(Entry B,D,F).  The best results were obtained when there reaction was performed at –78 
°C for one minute (Entry E).  The same experiments were performed with the addition 
CuI/HMPA, which have been shown to aid LAH in conjugate reductions, but offered no 
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Scheme 3.5.3:  Conjugate reduction using LAH. 
 









A rt 1 7 16 55 
B t 5 4 19 0 
C 0 1 15 24 30 
D 0 12 11 23 0 
E -78 1 32 32 34 
F -78 45 14 26 0 
Table 3.5.2:  Conditions for LAH reduction.  
 
 The next improvement came upon an observation using a new bottle of LAH. 
When the reduction was performed under the current conditions only a small amount of 
the products were obtained (~10% combined) with a poor mass balance.  It had then 
occurred to us that the bottle that we had been using was a bit older and postulated that 
 57 
moisture may have entered the original bottle thereby forming LAHx(OH)y adducts.   
These adducts would stand to be less reactive that pure LAH.   
 Previous studies had been done on the reactivity of LAH reagents modified with 
alkoxy groups by the Brown and Ashby Groups.
21,22
  The general trend they observed for 
reactivity of these adducts was OH ≥MeOH >EtOH > iPrO >>tBuOH.  The number of 
alkoxy groups on the LAH moiety also affected its reactivity, with the greater number of 
displaced hydrides the more reactivity decreased.  Based on previous results we decided 
to start the next set of experiments with a LAHx(EtO)y adducts (Table 3.5.3).  When only 
one hydride was displaced and the reaction run at -78 °C a bias toward the desired 
product was observed (Entry A).  When the reactivity was decreased by adding a second 













A LiAlH3OEt -78 15 40` 19 35 
B LiAlH2(OEt)2 -78 20 64 0 30 
C LiAlH(OEt)3 -78 60 0 0 99 
D LiAlH3OEt 0 5 20 35 35 
E LiAlH2(OEt)2   0 15 45 15 35 
F LiAlH2(OEt)2 rt 5 5 30 10 
Table 3.5.3: Conjugate reduction with LAH-ethoxy adducts.  
 
failed to provide any new results as was expected with only one available hydride.  As 
the temperature was raised yields decreased and the desired selectivity was lost (Entry C-
F).  The use of isopropoxy or tertbutoxy groups failed to provide any of the reduced 
products at low temperatures. When the reactions were run at high temperatures using 
 58 
these reagents (+60 °C) the starting material was consumed and inextricable mixtures 
were obtained.  
 The end result was a 65% yield of enone 84 when γ-hydroxy dienone 74 was 
treated to LAH2·OEt2 at – 78 °C (Scheme 3.5.4).  The crystal structure was obtained and 
the relative stereochemistry assigned (Figure 3.5.1).  It is clear that the hydrogen on the 
β-carbon was delivered from the bottom face, signaling that this was indeed a hydroxyl 
directed reduction.  The major drawback of this reaction is the purification.  It was very 
difficult to separate the starting material from the products.  As such, the subsequent 
transformation was undertaken with a mixture of dienone 74 and 84.  It is worthy of note 
that other reducing reagents/methods failed to give any positive results (Alane, Borane, 
DIBAL-H, and Birch).  
 
 














Figure 3.5.1: Crystal structure of enone 84. 
 
3.6 Cyclization 
The final step of our synthesis was the cyclization of enone 84.  It was initially 
envisioned that this transformation could be achieved via acid catalysis.  This method 










9 10  
Scheme 3.6.1: Nicolaou’s acid induced cyclization  
 
conditions were taken and applied to substrate 74 (Scheme 3.6.2).  The results were 
discouraging and surprising (Table 3.6.1).  At best only 6% of the desired product was 
obtained, along with epi-compound 87 and cyclized dienone 88 (Entry A).  Using 
stronger acids lead solely to the cyclized dienone (Entry B,C,E).
23
  When weaker acids 
 60 
were employed only the yield of cyclized dienone increased. (Entry D).  The formation of 
epi-compound 87 was not surprising, since it is known that tetrahydrofurans are readily 
cleaved under acidic conditions.  What was surprising was other sources reported this 















































A TFA DCM 2 0 6 3 56 
B TfOH DCM 1.5 -78 0 0 23 
C HCl Dioxane 2 0 0 0 28 
D AcOH neat 24 40 0 0 67 
E Nafion DCE 12 rt 0 0 60 
Table 3.6.1: Acid catalyzed conditions for the ether formation. 
 
 Short of any promising results we looked to inverting the stereochemistry of the 
secondary alcohol and perform an intramolecular SN2 displacement. This displacement 
would be done under basic conditions, thus avoiding the opening of the furan ring.  We 
began by exploring Mitsunobu chemistry (Table 3.6.2).  When standard or modified 
conditions were employed the starting material was destroyed (Entries A, B).
24
  It has 
been shown that Cyanomethylene/triemthylphosporane (CMMP/ Tsunoda’s Reagent), a 
modified Mitsunobu reagent, could enact an inversion and intramoleuclar cyclization in 
one pot.
25,26
  When CMMP was used only degradation products were isolated (Entry C).  
Foregoing Mitsunobu chemistry, Appel chemistry was attempted but that failed to give 
the desired bromide (Entry D).  The use of P2I4 resulted in degradation of starting 
material (Entry E).
27
  Attempting to form the bromide by displacing the mesylate also 
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A standard Mitsunobu  0 
B DEAD, Ph3P, Zn(OTs)2, THF, 3 hr 0 
C CMMP, THF, 65 °C, sealed tube 0 
D Ph3P, CBr4, DCM, rt 0 
E P2I4, THF, 0 °C, 5 h 0 
F MsCl, NEt3, DCM, rt then LiBr 0 
Table 3.6.2: Conditions for the inversion of the secondary alcohol. 
 
 Lacking any positive results from the previous experiments we looked at forming 
the cyclic ether by forming a carbonate moiety with the two hydroxyl groups.  With this 
compound we envisioned enforcing an intramolecular cyclization to produce compound 
11.  Initial attempts with thionyl chloride, phosgene and methyl carbonate all provided 
inextricable mixtures.  However, when DMSO was utilized we were able to affect the 











OH DMSO, 170 C
mw, 1 hr, 65%
84 11  
Scheme 3.6.5: Cyclization using DMSO. 
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We postulate that the ether formation is occurring via the tertiary carbocation.  Ionization 
of the hydroxyl group followed by ring closure from the secondary alcohol gives 
compound 11 (Figure 3.6.1).  We believe were able to achieve this etherification due to 
the relatively neutral reaction conditions, whereas when acidic conditions were employed 
only degradation and inversion products were isolated.  
  
 
Figure 3.6.1 Mechanism for the ether formation.   
 
3.7 Conclusion  
 We were able to achieve a concise, direct and stereoselective formal synthesis of 
platensimycin.  This was accomplished in 11 linear steps starting from commercially 
available 6-methoxy-1-tetralone in a 5% overall yield.  To date this is the shortest route to 
α-methyl enone 11. 
 Our original plan did not materialize for two reasons.  The first, a minor 
impediment, was the inability to successfully install the α-quaternary center using methyl 
acrylate.  This was circumvented with the use of allyl bromide in a Claisen 
rearrangement.  However, the issue of stereoselectivity was irreparable and forced us to 
re-work our strategy. 
 The second generation synthesis centered on forming the ether linkage prior to 

















improved due to serendipitous results.  The autoxidation of α-methyl dienone 58 proved 
to be a useful intermediate, shortening the planned synthetic route by 2 steps.  
Furthermore, we achieved the desired stereochemistry at all the newly formed 
stereocenters.  Finally, we were able to form the ether linkage in relatively neutral 
conditions to complete the formal synthesis of platensimycin.   
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Chapter 4: Experimental Section 
 
4.1 General Information 
 All moisture sensitive reactions were performed under an atmosphere of 
dry Ar, with glassware pre-dried at 125 °C. THF was dried via distillation over 
Na/benzophenone and 
t
BuOH by distillation over Na(m).  All other reagents or solvents 
were used as received, without further purification, unless otherwise stated.  Infrared 
spectra were recorded on a Nicolet FT-IR spectrophotometer in methylene chloride. 1H 
and 13C NMR spectra were recorded on a QE 300, Varian Unity+ 300 spectrometer at 300 
or 600 MHz and 75 or 150 MHz, respectively, and are reported in ppm relative to 
tetramethylsilane. All NMR spectra were taken with CDCl3 as solvent unless otherwise 
noted. Mass spectra were obtained on a VG ZAB2E or a Finnigan TSQ70. Column 





















 α-β Keto ester (54).  Sodium hydride (60% suspension in mineral oil, 3.4g, 85 
mmol) was added to methyl carbonate (71.0 mL, 740 mmol) under argon. After about 0.5 
h tetralone 22 (10.0 g, 56.8 mmol) was added to this suspension. The reaction mixture 
was heated to about 80 °C for about 5 h.  The reaction mixture was allowed to cool to 
ambient temperature and acidified with an aqueous solution of HCl (2M). The aqueous 
layer was then extracted with EtOAc (3 x 50 mL).  The organic layers were combined, 
washed with a saturated aqueous solution of NaHCO3 and brine, and dried over Na2SO4.  
The solvent was removed under reduced pressure to afford dark brown solid (13.3 g, 56.8 





H NMR (300 MHz, CDCl3): δ 8.03 (1H, d, J = 6.9 Hz), 6.85 (1H, dd, J 
= 6.9, 1.8 Hz), 6.70 (1H, d, J = 1.8), 3.87 (3H, s), 3.79 (3H, s), 3.61-3.57 (1H, m), 3.04-
2.96 (2H, m), 2.51-2.31 (2H, m); 
13
C NMR (75 MHz, CDCl3): δ 192.0, 171.1, 164.2, 
146.4, 130.5, 125.5, 113.7, 112.8, 55.7, 54.4, 52.6, 28.2, 26.7; HRMS calcd. for C13H15O4 
[MH
+









 Carboxylic Acid 24.  A crude mixture of 54 (56.8 mmol, crude), AcOH (140 
mL), 10% Pd/C (3.00 g, 2.83 mmol) and 70% HClO4 (5.0 mL, 83 mmol) was subjected 
to pressurized hydrogen gas (45 psi) for about 5 h.  After about 5 h NaOAc (3.5 g, 43 
mmol) was added and stirred for about 15 min.  The resulting mixture was filtered over 
celite, and the filtrate was concentrated in vacuo to produce a light brown oil. The crude 
mixture was dissolved in MeOH (75 mL). To this was added a solution of KOH (7.0 g, 
125 mmol), dissolved in H2O (75 mL), and maintained at ambient temperature for about 
7 h. The MeOH was removed under reduced pressure, and the resulting aqueous layer 
was washed with Et2O (2 x 50 mL).  The aqueous layer was then acidified with an 
aqueous solution of HCl (2M) and extracted with EtOAc (3 x 50 mL).  The organic 
extracts were combined, washed with water and brine, and dried over Na2SO4.  The 
solvent was then removed under reduced pressure to afford white solid 24 (9.8 g, 84% 




H NMR (300 MHz, 
CDCl3): δ 7.05 (1H, d, J = 8.4 Hz), 6.73 (1H, d, J = 8.4 Hz), 6.66 (1H, br s,), 3.80 (3H, 
s), 3.07-2.77 (5H, m), 2.28–2.24 (1H, m), 1.99–1.87 (1H, m); 
13
C NMR (75 MHz, 
CDCl3): δ 182.1, 158.0, 136.9, 130.2, 126.9, 113.6, 112.5, 55.5, 40.3, 30.9, 28.9, 25.8; 
176.6, 156.7, 136.1, 129.0, 126.4, 112.5, 111.3, 54.3, 39.1, 30.0, 27.9, 24.9; HRMS calcd 
for C12H15O3 [MH
+






 Diazoketone 57. Carboxylic acid 24 (4.00 g, 19.3 mmol) was dissolved in SOCl2 
(21 mL, 289 mmol) and stirred under argon for about 5 h at ambient temperature.  The 
thionyl chloride was removed under reduced pressure, and the resulting mixture was 
concentrated under vacuum (5mm).  The residue was dissolved in Et2O (20 mL) and 
added to a freshly prepared solution of diazomethane (3.42 g, 81.5 mmol) in Et2O (150 
mL) at about 0°C.  The reaction was maintained at about 0°C for about 30 min.  The 
reaction mixture was allowed to warm to ambient temperature and then gently refluxed 
for about 1 h.  The solvent was then removed under reduced pressure to produce 
diazoketone 57 as a yellow solid (4.73 g, 19.3 mmol).  The diazoketone was immediately 





NMR (300 MHz, CDCl3): δ 7.02 (1H, d, J = 8.4 Hz), 6.72 (1H, dd, J = 8.3, 2.7 Hz ), 6.65 
(1H, d, J = 2.4 Hz), 5.38 (1H, bs), 3.80 (3H, s), 2.93-2.83 (4H, m), 2.65 (1H, bs), 2.09–
2.07 (1H, m), 1.87–1.85 (1H, m); 
13
C NMR (75 MHz, CDCl3): δ 197.7, 158.0, 137.0, 
130.2, 127.2, 113.7, 112.5, 55.5, 54.1, 46.2, 31.3, 29.2, 26.3; HRMS calcd for 
C13H15N2O2[MH
+















 Dienone 25: Diazoketone 57 (4.73 g, 19.3 mmol, crude) was dissolved in DCM 
(20 mL) and cooled to about -10 °C.  TFA (10 mL) was then added slowly and the 
reaction was maintained at about -10 °C for about 30 min.  The reaction mixture was 
diluted with water (10 mL), removed from the cold bath, and neutralized with a saturated 
aqueous solution of NaHCO3.  The aqueous layer was extracted with DCM (3 x 30 mL).  
The organic extracts were then combined, washed with water and brine, and dried over 
Na2SO4.  The mixture was filtered and the solvent was removed in vacuo.  The crude 
product was purified by silica column chromatography (solvent gradient from 5/95 
EtOAc/Hex to 60/40 EtOAc/Hex) to produce dienone 25 as a yellow solid (2.19 g, 60% 




H NMR (300 MHz, 
CDCl3): δ 6.75 (1H, d, J = 9.6 Hz), 6.19 (1H, dd, J = 9.6, 1.8 Hz ), 5.98 (1H, d, J = 1.8 
Hz), 2.61-2.11 (6H, m), 1.98-1.90 (1H, m), 1.66-1.60 (2H, m); 
13
C NMR (75 MHz, 
CDCl3): δ 216.3, 186.5, 163.0, 152.1, 129.0, 124.2, 48.8, 46.6, 46.3, 42.1, 29.3, 28.7; 
HRMS calcd. for C12H13O2 [MH
+












Tertiary alcohol 26.  Dienone 25 (5.0 g, 27 mmol) was dissolved in anhydrous 
THF (78 mL) under argon and cooled to about -78 °C.  To the solution was added 3.0 M 
MeMgCl in THF (27 mL, 80 mmol), and the reaction was maintained at about -78 °C for 
about 4 h.  The reaction was removed from the cold bath, quenched with water (20 mL), 
and neutralized with a saturated aqueous solution of NH4Cl.  The aqueous layer was then 
extracted with EtOAc (3 x 50 mL).  The organic layers were combined, washed with 
brine and dried over Na2SO4.  The organic layer was then filtered and removed under 
reduced pressure.  The crude mixture was purified through silica column chromatography 
(solvent gradient from 5/95 EtOAc/DCM to 50/50 EtOAc/DCM).  Tertiary alcohol 26 
was obtained as a pale yellow solid (3.42 g, 63% yield). IR (thin film) 3403, 2955, 2936, 




H NMR (300 MHz, CDCl3): δ 6.68 (1H, d, J = 9.6 Hz), 
6.22 (1H, d, J = 9.9 Hz), 6.03 (1H, s), 2.98-2.86 (1H, m), 2.43 (1H, dd, J = 15.9, 6.3 Hz), 
2.28-2.17 ( 2H, m), 2.00 (1H, d, J = 14.4 Hz), 1.89 (1H, dd, J = 14.3, 2.4 Hz), 1.61-1.56 
(1H, m), 1.55 (3H, s), 1.50 (1H, dd, J = 11.1, 2.1 Hz); 
13
C NMR (75 MHz, CDCl3) δ 
187.4, 169.3, 154.6, 129.0, 122.1, 80.0, 51.2, 49.3, 46.8, 44.7, 33.1, 30.3, 28.1; HRMS 
calcd. for C13H17O2 [MH
+










α-Methyl dienone 58. Dienone 26 (3.00 g, 14.7 mmol) was dissolved in 
anhydrous 
t
BuOH (48 mL) under argon. To the reaction mixture 
t
BuOK (3.62 g, 32.3 
mmol) was added and the resulting solution was stirred at ambient temperature for about 
1 h.  Freshly distilled MeI (0.91 mL, 14.7 mmol) was added and the reaction mixture was 
maintained at ambient temperature for about 1 h.  The resulting mixture was quenched 
with water (15 mL) and then neutralized with an aqueous solution of HCl (1M).  The 
aqueous layer was extracted with EtOAc (3 x 35 mL).  The organic extracts were 
combined, washed with brine, and dried over Na2SO4.  The organic layer was then 
filtered and the solvent removed in vacuo.  The crude mixture was purified by silica 
column chromatography (solvent gradient from 5/95 EtOAc/Hex to 40/60 EtOAc/Hex).  
Methyl dienone 58 was obtained as pale yellow solid (1.96 g, 61%). IR (thin film) 2953, 




H NMR (300 MHz, CDCl3): δ 6.61 (1H, d, J = 10.2 
Hz), 6.23 (1H, d, J = 9.6 Hz), 2.81 (1H, dd, J = 16.2, 9 Hz), 2.74-2.67 (1H, m), 2.27-2.06 
(3H, m), 1.97 (1H, d, J = 14.7 Hz), 1.88 (3H, s), 1.84 (1H, dd, J = 14.7, 3.0 Hz), 1.67-
1.54 (1H, m), 1.53 (3H, s), 1.48 (1H, dd, J = 11.1, 2.4 Hz); 
13
C NMR (75 MHz, CDCl3): 
δ 165.6, 160.6, 153.9, 127.8, 79.7, 51.4, 48.7, 46.3, 43.9, 32.7, 29.6, 27.3, 25.8, 10.4; 
HRMS calcd. for C14H19O2 [MH
+








α-Allyl dienone 60.  Dienone 26 (200 mg, 0.98 mmol) was dissolved in 
anhydrous 
t
BuOH (5 mL) under argon.  To the reaction mixture 
t
BuOK (242 mg, 2.16 
mmol) was added, and the resulting solution was stirred at ambient temperature for about 
1 h.  Allyl bromide (0.09 mL, 0.98 mmol) was added, and the reaction mixture was 
maintained at ambient temperature for about 4 h. The reaction was quenched with water 
(5 mL) and neutralized with an aqueous solution of HCl (1M).  The aqueous layer was 
extracted with EtOAc (3 x 15 mL).  The organic extracts were combined, washed with 
brine, and dried over Na2SO4.  The organic layer was then filtered, and the solvent 
removed in vacuo.  The crude mixture was purified by silica column chromatography 
(solvent gradient from 5/95 EtOAc/Hex to 60/40 EtOAc/Hex).  Allyl dienone 60 was 





H NMR (300 MHz, CDCl3): δ 6.63 (1H, d, J = 9.6 Hz), 6.23 (1H, d, J 
= 9.3 Hz), 5.84-5.75 (1H, m), 4.95 (1H, s), 4.95 - 4.89 (1H, m), 3.18-3.16 (2H, m), 2.75-
2.68 (2H, m), 2.35 - 2.09 (3H, m), 1.97 (1H, d, J = 14.4), 1.90 (1H, dd, J = 14.4, 2.1 Hz), 
1.53 (3H, s), 1.49 – 1.45 (2H, m); 
13
C NMR (75 MHz, CDCl3): δ 185.9, 163.0, 154.4, 
135.0, 128.9, 128.2, 114.5, 80.1, 51.7, 49.2, 46.6, 44.6, 32.9, 28.7, 27.9, 26.1; HRMS 
calcd. for C16H21O2 [MH
+










61 65  
 
 Enones 61 and 65.  Dienone 26 (459 mg, 2.11 mmol) was dissolved in anhydrous 
t
BuOH (24 mL).  To the reaction mixture 
t
BuOK (1.71g, 6.31 mmol) was added, and the 
resulting solution was maintained at ambient temperature under argon for 1 h.  The 
solution was treated with allyl bromide (0.36 mL, 4.21 mmol) and the resulting solution 
was refluxed in a sealed tube for about 1 h.  The reaction was then quenched with water 
(15 mL) and neutralized with a saturated aqueous solution of NH4Cl.  The aqueous layer 
was then extracted with EtOAc (3 x 30 mL).  The organic layers were combined, washed 
with brine, and dried over Na2SO4.  The organic layer was filtered, and the solvent was 
removed under reduced pressure.  The crude mixture was purified by silica column 
chromatography (1:3 EtOAc/Hex).  Products 61 and 65 were obtained as white crystals in 








H NMR (300 MHz, 
CDCl3): δ 6.43 (1H, d, J = 9.0 Hz), 5.86 (1H, d, J = 10.2 Hz), 5.54-5.49 (2H, m), 4.92 
(2H, m), 2.72 (1H, dd, J= 14.7, 6.0 Hz), 2.51 (1H, dd, J=  17.7, 3.6 Hz), 2.41 (1H, dd, J = 
15.3, 7.2 Hz), 2.28-2.10 (5H, m), 1.86 (1H, d, J = 14.1 Hz), 1.8 (1H, d, J = 5.1 Hz), 1.74 
(1H, dd, J = 11.1, 3.0 Hz), 1.37 (3H, s), 1.25 (3H, s); 
13
C NMR (75 MHz, CDCl3): δ 
 77 
201.9, 153.3, 144.3, 135.2, 126.1, 121.2, 116.7, 79.8, 57.1, 50.1, 45.5, 44.2, 42.9, 40.0, 
31.4, 31.3, 29.0; HRMS calcd. for C17H22O2 [MH
+









H NMR (300 MHz, CDCl3): 
δ 6.49 (1H, d, J = 9.6 Hz), 5.92 (1H, d, J = 10.2 Hz), 5.68-5.62 (1H, m), 5.49 (1H, t, ), 
5.12-4.99 (2H, m), 2.60-2.53 (1H, m), 2.36- 2.19 (5H, m), 1.92-1.86 (2H, m), 1.74 
(1H,dd, J = 11.1, 3.6 Hz), 1.45 (3H, s), 1.21 (3H, s); 
13
C NMR (75 MHz, CDCl3): δ 
202.1, 153.2, 143.2, 133.2, 125.4, 121.3, 118.5, 79.9, 55.4, 51.4, 45.2, 45.2 44.7, 43.5, 
31.3, 29.2, 17.7; HRMS calcd. for C17H22O2 [MH
+


















γ-Hydroxy dienone 74. A biphasic system was prepared by dissolving KOH (1 g, 
17.8 mmol) in 
t
BuOH (4.5 g) and water (4.5 mL).  A portion of the aqueous layer (2 mL) 
and a portion of the organic layer (2 mL) were combined and treated with compound 58 
(100 mg, 0.46 mmol) at ambient temperature.  Following dissolution of 58, the mixture 
was treated with N(n-Bu)4Br (147.7 mg, 0.46 mmol) and maintained at ambient 
temperature, open to atmosphere, for about 2 days.  The reaction mixture was then 
diluted with water (5 mL) and neutralized with an aqueous solution of HCl (1 M).  The 
aqueous layer was extracted with EtOAc (3x10 mL).  The organic layers were combined, 
washed with brine, and dried over Na2SO4.  The crude mixture was filtered and the 
solvent removed under reduced pressure. After column chromatography (solvent gradient 
from 5/95 EtOAc/DCM to 40/60 EtOAc/DCM), hydroxyl dienone 74 was obtained as a 





NMR (300 MHz, CDCl3): d, J = 9.6 Hz),d, J = 9.6 Hz),5.17 (1H, 
br),4.97 (1H, d, J = 6.0 Hz), 4.85 (1H, br), 2.42 (1H, d, J = 15.3 Hz), 2.22-2.17 (2H, m), 
2.12-2.02 (2H, m), 1.96 (3H, s),1.93-1.84 (3H, m), 1.49 (3H, s); 
13
C NMR (75 MHz, 
CDCl3): 187.6, 157.4, 155.7, 131.5, 127.7, 79.2, 65.0, 50.9, 48.1, 46.6, 43.7, 35.1, 31.2, 
10.7;RMS calcd. for C14H19O3 [MH
+












H NMR (300 
MHz, CDCl3): d, J = 10.2 Hz), d, J = 9.9 Hz), 3.13 (1H, d, J = 16.2 
Hz), 2.51-2.35 (3H, m), 2.31 (1H, s) 2.09 (3H, s), 1.99 (1H, dd, J = 12.3, 2.6 Hz). 1.87 
(1H, dd, J = 15.0, 2.6 Hz), 1.55 (3H, s); 
13
C NMR (75MHz, CDCl3): δ 202.2, 186.9, 
153.5, 152.2, 134.8, 128.4, 79.8, 51.5, 49.7, 46.9, 46.2, 43.5, 32.1, 10.7;RMS calcd. for 
C14H17O3 [MH
+











H NMR (600 
MHz, CDCl3): d, J =4.8 Hz),d, J = 4.8 Hz),5.95 (1H, t, J = 0.9 
Hz), 2.97 (1H, bs), 2.61-2.56 (1H, m), 2.44-2.55 (1H, bs), 2.27-2.23 (2H, m), 2.16 (1H, 
dd, J = 7.5, 1.5 Hz), 1.91 (1H, d, J = 6.9 Hz), 1.88-1.85 (1H, m), 1.74 (1H, dd, J = 5.7, 
1.8 Hz), 1.47 (3H, s), 1.38 (3H, s); 
13
C NMR (150 MHz, CDCl3): δ 198.1, 154.1, 143.3, 
125.2, 124.8, 79.6, 74.0, 57.8, 45.8, 45.0, 42.3, 31.5, 29.3, 23.8;RMS calcd. for 
C14H19O3 [MH
+













Silyloxy dienone 81. A solution of 
i
Pr2SiHCl (0.09mL, 0.52mmol), DMAP (20mg, 17 
mmol), Et3N (0.072 mL, 17 mmol) dissolved in DCM (8 mL) was added a solution of γ-
hydroxy dienone 74 (100 mg, 0.13 mmol) in DCM (6 mL) via syringe.  The reaction was 
maintained at ambient temperature for about 12 h.  The reaction was then diluted with 
water (15 mL) and extracted with DCM (3 x 15 mL).  The organic layers were combined, 
washed with brine, and dried over Na2SO4.  The solvent was removed under reduced 
pressure and purified by column chromatography (5:95 EtOAc/Hex). The silyloxy 
dienone was obtained as a yellow solid (119 mg, 99%). IR (thin film) 3290, 2940, 2865, 




H NMR (300 MHz, CDCl3): d, J =9.9 
Hz),d, J = 9.9 Hz),4.99 (1H, d, J = 6.0 Hz), 4.23 (1H, s), 2.44 (1H, d, 15.3), 
2.23-2.18 (2H, m), 2.14-2.03 (3H, m), 1.99 (3H, s), 1.95-1.87 (1H, m) 1.51 (3H, s) 1.11-
0.98 (14H, m);
 13
C NMR (75 MHz, CDCl3): δ 187.5, 157.2, 155.4, 131.6, 127.8, 79.2, 
65.2, 51.9, 48.0, 46.6, 43.6, 35.0, 31.3, 17.4, 12.9, 10.7; RMS calcd. for C20H33O3Si 
[MH
+










Enone 84. Dienone 74 (50 mg, 0.21 mmol) was dissolved in THF (2.13 mL) and 
cooled to about -78

C under an atmosphere of argon.  To the resulting solution was added 
LiAH2(OEt)2 (0.12 mL, 1.8 M, 0.21 mmol).  After about 0.5 h the reaction was 
quenched with MeOH (5mL) and diluted with water (10 mL).  The solution was 
neutralized with an aqueous solution of HCl (1M).  The resulting solution was extracted 
with EtOAc (3x10 mL).  The organic layers were combined, washed with brine, and 
dried over Na2SO4.  The solvent was removed in vacuo and to give pale yellow oil.  The 
crude mixture was purified by column chromatography (5-50% EtOAc/DCM) to provide 
a mixture (2:1) of enone 84 and dienone 74 (48 mg, 64%) as a white solid. IR (thin film) 




H NMR (300 MHz, CDCl3):  6.63 (1H, d, J 
= 9.9 Hz), 5.93 (1H, d, J = 9.9 Hz), 4.15 (1H, d, J = 5.4 Hz), 2.44 (1H, d, J = 2.1 Hz), 
2.39-2.2.29 (3H, m),2.11-2.03 (2H, m), 1.91-1.83 (2H, m), 1.73-1.63 (2H, m), 1.46 (3H, 
s), 1.31-1.18 (3H, m);

C (75 MHz, CDCl3): 20.2, 158.8, 127.8, 78.9, 67.2, 55.9, 53.5, 























Cyclized enone 11. A mixture (2:1) of compounds 74 and 84 (50 mg, 0.13 mmol) 
was dissolved in DMSO (1 mL) and delivered to a microwave reaction vessel.  The 
reaction was heated for about 1 h at 170 

C.  The reaction was allowed to cool to ambient 
temperature, and water was added (3 mL).  The resulting solution was extracted with 
Et2O (3x10 mL). The organic layers were combined, washed with brine, and dried over 
Na2SO4. The solvent was removed under reduced pressure resulting in dark brown oil.  
The crude mixture was purified by column chromatography (solvent gradient from 0/100 
EtOAc/hexanes to 30/70 EtOAc/hexanes) to give 11 (21 mg, 65%). IR (thin film) 2962, 




H NMR (600 MHz, CDCl3): d, J= 9.6 
Hz),d, J = 9.6 Hz),4.33 (1H, t, J = 4.2 Hz), 2.37-2.30 (2H, m), 2.05 (1H, d, J 
= 13.8 Hz), 1.96-1.91 (1H, m), 1.92-1.88 (1H, m), 1.85 (1h, d, J = 11.4 Hz), 1.77 (1H, 
dd, J= 12, 3.6 Hz), 1.73-1.70 (1H, m), 1.6 (1H, d, J = 10.8), 1.42 (3H, s), 1.11 (3H, d, J = 
6.6 Hz); 
13
C NMR (75 MHz, CDCl3): δ 201.6, 154.4, 128.4, 87.1, 77.9, 52.1, 48.8, 46.8, 
44.6, 42.8, 41.5, 37.4, 23.3, 11.2. RMS calcd. for C14H19O2 [MH
+









4.3 Supporting Information 
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X-ray experimental for 61: 
 
 Crystals grew as colorless needles by slow evaporation of the mother liquor.  The 
data crystal was a needle that had approximate dimensions; 0.38 x 0.09 x 0.06 mm.  The 
data were collected on a Nonius Kappa CCD diffractometer using a graphite 
monochromator with MoK radiation ( = 0.71073Å).  A total of 348 frames of data 
were collected using -scans with a scan range of 0.8 and a counting time of 140 
seconds per frame.  The data were collected at 153 K using an Oxford Cryostream low 
temperature device.  Details of crystal data, data collection and structure refinement are 
listed in Table 1.  Data reduction were performed using DENZO-SMN.
1
  The structure 
was solved by direct methods using SIR97
2
 and refined by full-matrix least-squares on F2 
with anisotropic displacement parameters for the non-H atoms using SHELXL-97.
3
  The 
hydrogen atoms on carbon were calculated in ideal positions with isotropic displacement 
parameters set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms).  
The hydrogen atoms bound to the hydroxyl oxygen atoms were observed in a F map 
and refined with isotropic displacement parameters.  The direction of the polar z axis 
could not be determined from the X-ray data and was arbitrarily assigned.  The function, 
w(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[((Fo))2 + (0.0573*P)2 + (0.8863*P)] 
and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.147, with R(F) equal to 0.0676 and a 
goodness of fit, S, = 1.06.  Definitions used for calculating R(F), Rw(F2) and the 
goodness of fit, S, are given below.4  The data were checked for secondary extinction 
effects but no correction was necessary.  Neutral atom scattering factors and values used 
to calculate the linear absorption coefficient are from the International Tables for X-ray 




Table 4.1.  Crystal data and structure refinement for 71 
 
 
Empirical formula  C17 H22 O2 
Formula weight  258.35 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 17.7100(5) Å  
 b = 8.4320(10) Å  
 c = 19.4690(13) Å  
Volume 2907.3(4) Å3 
Z 8 
Density (calculated) 1.180 Mg/m3 
Absorption coefficient 0.075 mm-1 
F(000) 1120 
Crystal size 0.38 x 0.09 x 0.06 mm 
Theta range for data collection 2.09 to 24.99°. 
Index ranges -20<=h<=21, -10<=k<=10, -23<=l<=23 
Reflections collected 4831 
Independent reflections 2635 [R(int) = 0.0990] 
Completeness to theta = 24.99° 99.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2635 / 25 / 355 
Goodness-of-fit on F2 1.062 
Final R indices [I>2sigma(I)] R1 = 0.0676, wR2 = 0.1220 
R indices (all data) R1 = 0.1417, wR2 = 0.1471 





Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 61.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
O1 -1747(3) 5207(6) 3522(3) 58(2) 
O2 1773(3) 8388(6) 3528(2) 44(1) 
C1 -1212(4) 5867(9) 3790(4) 43(2) 
C2 -411(4) 5229(8) 3669(3) 37(2) 
C3 196(4) 6078(9) 4101(4) 36(2) 
C4 869(4) 5399(9) 4221(4) 41(2) 
C5 1505(4) 6219(10) 4584(5) 43(2) 
C6 1343(5) 7953(12) 4721(5) 43(2) 
C7 1314(4) 9011(8) 4070(4) 39(2) 
C8 465(4) 8922(9) 3825(4) 42(2) 
C9 58(6) 7774(10) 4331(5) 38(2) 
C10 -744(4) 8160(10) 4416(3) 40(2) 
C11 -1310(6) 7322(8) 4178(5) 34(3) 
C12 521(4) 8055(11) 4999(3) 39(2) 
C13 -451(4) 3411(8) 3824(4) 50(2) 
C14 -645(5) 3028(11) 4552(5) 59(2) 
C15 -1301(7) 2447(10) 4764(7) 65(4) 
C16 -241(4) 5477(9) 2896(4) 53(2) 
C17 1542(4) 10712(8) 4228(4) 53(2) 
O1A 4245(3) 4882(6) 2422(3) 56(1) 
O2A 718(3) 1636(7) 2455(3) 48(1) 
C1A 3707(4) 4192(8) 2160(4) 40(2) 
C2A 2913(3) 4836(8) 2253(4) 41(2) 
C3A 2302(4) 3958(9) 1846(4) 36(2) 
C4A 1642(4) 4587(8) 1694(4) 42(2) 
C5A 1013(5) 3708(11) 1353(5) 52(2) 
C6A 1186(4) 1949(11) 1258(4) 41(2) 
 112 
C7A 1196(4) 1001(8) 1931(4) 38(2) 
C8A 2023(4) 1111(8) 2167(4) 35(2) 
C9A 2421(5) 2228(10) 1663(5) 32(2) 
C10A 3242(4) 1791(9) 1589(4) 40(2) 
C11A 3817(7) 2697(9) 1785(6) 45(3) 
C12A 1983(4) 1808(10) 1001(4) 43(2) 
C13A 2940(4) 6608(9) 2077(4) 51(2) 
C14A 3136(6) 6948(12) 1350(5) 66(3) 
C15A 3750(8) 7610(9) 1133(8) 72(4) 
C16A 2737(4) 4660(10) 3029(4) 53(2) 
































X-ray: Experiment for 65: 
 
 Crystals grew as clusters of small, colorless needles by evaporation of the mother 
liquor.  The data crystal was cut from a cluster of crystals and had approximate 
dimensions; 0.19 x 0.09 x 0.08 mm.  The data were collected on a Nonius Kappa CCD 
diffractometer using a graphite monochromator with MoK radiation ( = 0.71073Å).  A 
total of 201 frames of data were collected using -scans with a scan range of 1.1 and a 
counting time of 260 seconds per frame.  The data were collected at 153 K using an 
Oxford Cryostream low temperature device.  Details of crystal data, data collection and 
structure refinement are listed in Table 1.  Data reduction were performed using DENZO-
SMN.
1
  The structure was solved by direct methods using SIR97
2
 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms 
using SHELXL-97.
3
  The hydrogen atoms on carbon were calculated in ideal positions 
with isotropic displacement parameters set to 1.2xUeq of the attached atom (1.5xUeq for 
methyl hydrogen atoms).  The hydrogen atom bound to O2 was observed in a F map 
and refined with an isotropic displacement parameter.  The absolute configuration of the 
molecule was assigned arbitrarily.  The function, w(|Fo|2 - |Fc|2)2, was minimized, 
where w = 1/[((Fo))2 + (0.0268*P)2 + (0.5635*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) 
refined to 0.144, with R(F) equal to 0.0758 and a goodness of fit, S, = 1.03.  Definitions 
used for calculating R(F), Rw(F2) and the goodness of fit, S, are given below.4  The data 
were checked for secondary extinction effects but no correction was necessary.  Neutral 
atom scattering factors and values used to calculate the linear absorption coefficient are 




Table 1.  Crystal data and structure refinement for 65 
 
Empirical formula  C17 H22 O2 
Formula weight  258.35 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.1420(6) Å  
 b = 10.0850(16) Å  
 c = 19.6410(10) Å  
Volume 1414.7(3) Å3 
Z 4 
Density (calculated) 1.213 Mg/m3 
Absorption coefficient 0.078 mm-1 
F(000) 560 
Crystal size 0.19 x 0.09 x 0.08 mm 
Theta range for data collection 2.07 to 24.99°. 
Index ranges -8<=h<=8, -11<=k<=11, -23<=l<=23 
Reflections collected 2463 
Independent reflections 2463 [R(int) = 0.0000] 
Completeness to theta = 24.99° 99.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2463 / 0 / 178 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0758, wR2 = 0.1098 
R indices (all data) R1 = 0.2182, wR2 = 0.1443 
Absolute structure parameter 5(4) 





Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 65.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
O1 2540(5) 5598(4) 4291(2) 44(1) 
O2 2918(6) 4878(4) 7836(2) 48(1) 
C1 2248(8) 5728(5) 4904(3) 29(1) 
C2 3452(7) 5011(5) 5437(2) 29(1) 
C3 3560(7) 5803(5) 6093(2) 26(1) 
C4 5118(8) 5916(5) 6456(3) 36(2) 
C5 5241(8) 6622(6) 7125(2) 43(2) 
C6 3317(8) 7126(6) 7367(3) 42(2) 
C7 1942(7) 6030(5) 7589(3) 34(2) 
C8 888(7) 5666(6) 6938(3) 37(2) 
C9 1789(7) 6460(6) 6353(2) 32(2) 
C10 429(8) 6775(5) 5801(3) 40(2) 
C11 626(8) 6479(6) 5149(3) 39(2) 
C12 2338(8) 7740(6) 6749(2) 42(2) 
C13 2413(8) 3668(5) 5557(2) 37(2) 
C14 3379(7) 2791(6) 6068(3) 35(2) 
C15 4039(7) 1590(6) 5932(3) 41(2) 
C16 5375(7) 4702(5) 5128(2) 37(2) 


















X-ray Experimental for 74: 
 
 Crystals grew as colorless needles by slow evaporation from dichloromethane and 
hexanes.  The data crystal was a long lathe that had approximate dimensions; 0.53 x 0.08 
x 0.07 mm.  The data were collected on a Nonius Kappa CCD diffractometer using a 
-scans with a scan range of 1.5 and a counting time of 108 
seconds per frame.  The data were collected at 153 K using an Oxford Cryostream low 
temperature device.  Details of crystal data, data collection and structure refinement are 
listed in Table 1.  Data reduction were performed using DENZO-SMN.
1
  The structure 
was solved by direct methods using SIR97
2
 and refined by full-matrix least-squares on F2 
with anisotropic displacement parameters for the non-H atoms using SHELXL-97.
3
  The 
hydrogen atoms on carbon were calculated in ideal positions with isotropic displacement 
parameters set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms).  
The hydroxyl group hydrogen atoms were observed in a F map and refined with 
isotropic displacement parameters.  The function, w(|Fo|2 - |Fc|2)2, was minimized, 
o))2 + (0.044*P)2 + (0.2463*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) 
refined to 0.0967, with R(F) equal to 0.0481 and a goodness of fit, S, = 1.04.  Definitions 
used for calculating R(F), Rw(F2) and the goodness of fit, S, are given below.4   Neutral 
atom scattering factors and values used to calculate the linear absorption coefficient are 
from the International Tables for X-ray Crystallography (1992).5  All figures were 
generated using SHELXTL/PC.6  Tables of positional and thermal parameters, bond 
lengths and angles, torsion angles, figures and lists of observed and calculated structure 
factors are located in tables 1 through through 7.   
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Table 1.  Crystal data and structure refinement for 74. 
 
Empirical formula  C14 H18 O3 
Formula weight  234.28 
Temperature  153(2) K 
Wavelength  0.71070 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 7.7775(5) Å  
 b = 20.9924(12) Å  
 c = 7.4165(5) Å  
Volume 1210.88(13) Å3 
Z 4 
Density (calculated) 1.285 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 504 
Crystal size 0.53 x 0.08 x 0.07 mm 
Theta range for data collection 1.94 to 27.48°. 
Index ranges -10<=h<=10, -26<=k<=26, -9<=l<=9 
Reflections collected 2542 
Independent reflections 1489 [R(int) = 0.0398] 
Completeness to theta = 27.48° 99.7 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1489 / 1 / 164 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0481, wR2 = 0.0892 
R indices (all data) R1 = 0.0725, wR2 = 0.0967 






Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 74.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________ 
O1 4177(2) 1755(1) 2960(3) 38(1) 
O2 1419(3) 48(1) 7768(3) 31(1) 
O3 -1517(3) 357(1) 9368(3) 31(1) 
C1 3248(3) 1711(1) 4295(4) 27(1) 
C2 3422(3) 1174(1) 5584(4) 26(1) 
C3 2365(3) 1124(1) 7018(4) 22(1) 
C4 2493(4) 571(1) 8328(4) 28(1) 
C5 1967(4) 739(1) 10255(4) 29(1) 
C6 480(3) 1220(1) 10381(4) 29(1) 
C7 -1174(3) 1034(1) 9342(4) 29(1) 
C8 -857(3) 1275(1) 7393(4) 27(1) 
C9 945(3) 1606(1) 7390(4) 24(1) 
C10 945(3) 2152(1) 6121(4) 30(1) 
C11 1960(3) 2199(1) 4680(4) 31(1) 
C12 1058(3) 1821(1) 9397(4) 29(1) 
C13 4810(4) 703(1) 5114(5) 38(1) 





















X-ray Experimental for 84: 
 
 X-ray Experimental for C14H20O3:   Crystals grew as colorless plates by slow 
evaporation from dichloromethane/hexanes.  The data crystal had approximate 
dimensions; 0.25 x 0.25 x 0.08 mm.  The data were collected on a Nonius Kappa CCD 
diffractometer using a graphite monochromator with MoK radiation ( = 0.71073Å).  A 
total of 209 frames of data were collected using -scans with a scan range of 2 and a 
counting time of 288 seconds per frame.  The data were collected at 153 K using an 
Oxford Cryostream low temperature device.  Details of crystal data, data collection and 
structure refinement are listed in Table 1.  Data reduction were performed using DENZO-
SMN.
1
  The structure was solved by direct methods using SIR97
2
 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms 
using SHELXL-97.
3
  The hydrogen atoms were calculated in ideal positions with 
isotropic displacement parameters set to 1.2xUeq of the attached atom (1.5xUeq for 
methyl hydrogen atoms).  The function, w(|Fo|2 - |Fc|2)2, was minimized, where w = 
1/[((Fo))2 + (0.0493*P)2 + (0.4359*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 
0.122, with R(F) equal to 0.0488 and a goodness of fit, S, = 1.04.  Definitions used for 
calculating R(F),Rw(F2) and the goodness of fit, S, are given below.4  The data were 
checked for secondary extinction but no correction was necessary.  Neutral atom 
scattering factors and values used to calculate the linear absorption coefficient are from 
the International Tables for X-ray Crystallography (1992).5  All figures were generated 
using SHELXTL/PC.6  Tables of positional and thermal parameters, bond lengths and 




Table 1.  Crystal data and structure refinement for 84. 
 
Empirical formula  C14 H20 O3 
Formula weight  236.30 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 10.516(2) Å  
 b = 8.0642(16) Å  
 c = 15.392(3) Å  
Volume 1281.0(4) Å3 
Z 4 
Density (calculated) 1.225 Mg/m3 
Absorption coefficient 0.085 mm-1 
F(000) 512 
Crystal size 0.25 x 0.25 x 0.08 mm 
Theta range for data collection 1.97 to 27.49°. 
Index ranges -13<=h<=13, -10<=k<=10, -19<=l<=19 
Reflections collected 5523 
Independent reflections 2928 [R(int) = 0.0224] 
Completeness to theta = 27.49° 99.4 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2928 / 0 / 164 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0488, wR2 = 0.1112 
R indices (all data) R1 = 0.0723, wR2 = 0.1225 
Largest diff. peak and hole 0.233 and -0.153 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 84.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________   
C1 5822(2) 1939(2) 6346(1) 39(1) 
C2 6349(1) 3225(2) 7049(1) 33(1) 
C3 7585(1) 4091(2) 6885(1) 27(1) 
C4 7989(2) 5552(2) 7535(1) 36(1) 
C5 7457(2) 7234(2) 7175(1) 41(1) 
C6 7424(2) 7495(2) 6184(1) 36(1) 
C7 8732(1) 7230(2) 5886(1) 36(1) 
C8 8774(1) 5321(2) 5728(1) 34(1) 
C9 7489(1) 4609(2) 5909(1) 27(1) 
C10 7018(2) 3182(2) 5315(1) 36(1) 
C11 6263(2) 1974(2) 5508(1) 36(1) 
C12 6589(1) 6120(2) 5685(1) 35(1) 
C13 6544(2) 2413(2) 7966(1) 52(1) 
C14 8792(2) 8213(2) 5052(1) 55(1) 
O1 5016(2) 922(2) 6470(1) 74(1) 
O2 9376(1) 5710(2) 7761(1) 47(1) 
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